Hormos Licenses HMRlignan to Linnea

Hormos Medical Corporation, Turku, Finland, has licensed its dietary supplement ingredient HMRlignan to Linnea SA, Locarno, Switzerland. HMRlignan is a plant lignan, 7-hydroxymatairesinol, isolated and purified from Norway spruce (Picea abies). In humans, 7-hydroxyma­tairesinol is converted into mammalian lignan, enterolactone. HMRlignan is a highly purified lignan, which effectively elevates the enterolactone level already at milligram doses. In May 2004 Hormos obtained new dietary ingredient (NDI) clearance from the FDA, which allows HMRlignan-containing dietary supplements to be marketed in the U.S.